| BUPIVACAINE; MELOXICAM | None | ||
| 60MG/2.3ML;1.8MG/2.3ML, 200MG/7ML;6MG/7ML, 300MG/10.5ML;9MG/10.5ML, 400MG/14ML;12MG/14ML |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| ZYNRELEF contains bupivacaine, an amide local anesthetic, and meloxicam, a nonsteroidal anti-inflammatory drug (NSAID), and is indicated in adults for soft tissue or periarticular instillation to produce postsurgical analgesia for up to 72 hours after foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures. | |||
|
Yes
| |||
| ZYNRELEF KIT | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 | Patent 16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | ||||||||||||||||
| ************ ** * ************** *** ** ******* ******* | ****-****** ********* ******** ******* | ************ ** * ************** *** ** ******* ******* | ****-****** ********* ******** ******* | ************ ** * ************** *** ** ******* ******* | ****-****** ********* ******** ******* | ****-****** ********* ******** ******* | ************ ** * ************** *** ** ******* ******* | ****-****** ********* ******** ******* | ****-****** ********* ******** ******* | ************ ** * ************** *** ** ******* **** ********* | ****-****** ********* ******** ******* | ****-****** ********* ******** ******* | ************ ** * ************** *** ** ******* ******* | ****-****** ********* ******** ******* | ************ ** * ************** *** ** ******* **** ********* |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|